Assessment of the Efficacy of Carnipure® AAS on Body Composition, Muscle Thickness, and Strength Adaptations in Healthy Men

Inclusion Criteria: * Healthy male subjects 18-40 years old * Recreationally trained (\<1-year of training experience) * Not currently consuming any ergogenic supplements or performance enhancing drugs * Body mass index (BMI) 18-35 kg/m2 * No recent injuries that would contraindicate participation in a resistance training program * Willing and able to give written informed consent * Able to read, understand, sign and date the informed consent document (English only) * Able and willing to comply with the schedule visit(s) and study requirements. Exclusion Criteria: * Currently taking (within the past 30 days) ergogenic dietary supplements including, creatine, protein, amino acids, or stimulants other than caffeine (yohimbe, ephedrine, etc.) * Currently taking performance enhancing drugs (testosterone or other anabolic-androgenic steroids), human growth hormone, insulin, etc. * History or current malignancy * Receiving chemotherapy agents or radiation treatments * Musculoskeletal disease (muscular dystrophy, arthritis, etc.) * Recent (\<3-months) musculoskeletal injuries * BMI \<18 or \>5 kg/m2 * Diagnosis of a terminal illness * Use of prescription medications that influence muscle anabolism (i.e., prescription hormone therapies, etc.) * History of alcohol abuse * History or current drug abuse * History or current cigarette smoke (including vaping) within the past 14 days from the screening visit * Insulin-dependent diabetes and/or metformin use * Chronic kidney or liver disease * Has significant concurrent illnesses (controlled or uncontrolled), such as diabetes, lupus, epilepsy, or cardiac disorders, hepatitis B/C, HIV, serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years, or other, which in the opinion of the investigator, such conditions might be aggravated as a result of treatment * The investigator feels that for any reason the subject is not eligible to participate in the study * History of uncontrolled cardiovascular disease (i.e., myocardial infarction, hypertension, hypercholesterolemia, peripheral vascular disease, other) * Developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to follow study subject requirement and/or record the necessary study measurements * A family member of the investigator or an employee of the investigator * Participation in any other investigational study within 30 days prior to consent.